Pablo Raffaele

ORCID: 0000-0002-9726-4509
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Transplantation Outcomes and Treatments
  • Renal and Vascular Pathologies
  • Organ Transplantation Techniques and Outcomes
  • Organ Donation and Transplantation
  • Transplantation: Methods and Outcomes
  • Diabetes Treatment and Management
  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Complement system in diseases
  • Neurological Complications and Syndromes
  • Liver Disease and Transplantation
  • Heart Failure Treatment and Management
  • Potassium and Related Disorders
  • Organ and Tissue Transplantation Research
  • Parathyroid Disorders and Treatments
  • Renal and related cancers
  • Pancreatic function and diabetes
  • Dialysis and Renal Disease Management
  • Renal function and acid-base balance
  • Bone health and treatments
  • Pharmaceutical Practices and Patient Outcomes
  • Metabolism and Genetic Disorders
  • Viral-associated cancers and disorders
  • Diabetes Management and Research
  • Medication Adherence and Compliance

Favaloro Foundation
2009-2024

Fundacion Favaloro Hospital Universitario
2011-2024

Favaloro University
2020-2024

Steno Diabetes Centers
2021

University of Copenhagen
2021

Otto-von-Guericke University Magdeburg
2014

Peoples' Friendship University of Russia
2014

St. Vincent's Hospital
2014

Hospital Terrassa
2014

Hospital San Pedro de Alcántara
2014

Hiddo J.L. Heerspink C. David Sjöström Niels Jongs Glenn M. Chertow Mikhail Kosiborod and 95 more Fan Fan Hou John J.V. McMurray Peter Rossing Ricardo Correa–Rotter Raisa Kurlyandskaya Bergur V. Stefánsson Robert D. Toto Anna Maria Langkilde David C. Wheeler Hiddo J.L. Heerspink David C. Wheeler Glenn M. Chertow Ricardo Correa–Rotter Tom Greene Fan Fan Hou John J.V. McMurray Peter Rossing Robert D. Toto Bergur V. Stefánsson Anna Maria Langkilde Laura Maffei Pablo Raffaele S. Solís César A. Arias Dov Aizenberg Carolina Lúquez Cesar Javier Zaidman Natalia Cluigt M. Mayer A Alvarisqueta A. Wassermann Rafaël Maldonado J. Bittar M. Maurich L.E. Gaite Nicole Garcia Leonardo Sivak Pablo Ramallo Juan Carlos Santos Ruben Garcia Duran Juan Oddino A Marañón Lília Nigro Maia Dánae Duana Ávila Elvino Barros Maria H Vidotti Daniel Panarotto Irene de Lourdes Noronha Luiz Alberto Andreotti Turatti Luciane Mônica Deboni María Eugênia Fernandes Canziani Miguel C. Riella Marcelo Rodrigues Bacci Raphael Paschoalin R. J. Franco João Carlos Goldani Eric St-Amour Ann Steele Ronald Goldenberg S.B. Pandeya Harpreet S. Bajaj David Z.I. Cherney Stéphanie Kaiser James Conway Sharron Chow G.S. Bailey Jean‐Philippe Lafrance Jonathan Winterstein Serge Cournoyer Daniel Gaudet F. Madore Robyn L. Houlden Ashley Dowell Michel R. Langlois Nicola Muirhead Hasnain Khandwala Anna S. Levin Fan Fan Hou Ying Xue Zuo Li Chuan‐Ming Hao Zhaohui Ni Xing Changying N Chen Yugang Dong Rong Zhou Xiao Xu Yiping Zou Chu Wang Liu B Qian Chen Miao Lin Qin Luo David Zhang Jing Wang

Mortality rates from chronic kidney disease (CKD) have increased in the last decade. In this pre-specified analysis of DAPA-CKD trial, we determined effects dapagliflozin on cardiovascular and non-cardiovascular causes death.DAPA-CKD was an international, randomized, placebo-controlled trial with a median 2.4 years follow-up. Eligible participants were adult patients CKD, defined as urinary albumin-to-creatinine ratio (UACR) 200-5000 mg/g estimated glomerular filtration rate (eGFR) 25-75...

10.1093/eurheartj/ehab094 article EN cc-by-nc European Heart Journal 2021-02-09
Zien Zhou Meg Jardine Qiang Li Brendon L. Neuen Christopher P. Cannon and 95 more Dick de Zeeuw Robert Edwards Adeera Levin Kenneth W. Mahaffey Vlado Perkovic Bruce Neal Richard I. Lindley Rodolfo Andrés Ahuad Guerrero Diego Aizenberg Juan Pablo Albisu Andres Alvarisqueta Ines Bartolacci Mario Alberto Berli Anselmo P. Bordonava Pedro Calella Maria Cecilia Cantero Luis Cartasegna Esteban Cercos Gabriela Cecilia Coloma Hugo Colombo Victor Commendatore Jesus Cuadrado Carlos Alberto Cuneo Ana María Cusumano Walter Douthat Ricardo D. Dran Eduardo Farias María Florencia Fernández Hernan Finkelstein Guillermo Fragale Jose Osvaldo Fretes Néstor H. García Anibal Gastaldi Elizabeth Gelersztein Jorge Archibaldo Glenny Joaquin Pablo Gonzalez Patricia del Carmen Gonzalez Colaso Claudia Goycoa Gustavo Greloni Adrián Guinsburg Sonia Hermida Luis I. Juncos Maria Isabel Klyver Florencia Kraft Fernando Krynski Paulina Virginia Lanchiotti Ricardo Alfonso Leon de la Fuente Nora Marchetta Pablo G. Mele Silvia Nicolai P. Novoa Silvia Ines Orio Fabián Otreras Alejandra Oviedo Pablo Raffaele Jorge Hector Resk Lucas Rista Nelson Papini Jorgelina Sala Juan Carlos Santos Lilia Beatriz Schiavi Horacio Sessa Tomas Smith Casabella María Rosa Ulla María Valdez Augusto Vallejos Adriana Villarino Virginia Esther Visco Alfredo Wassermann Cesar Javier Zaidman N. Wah Cheung Carolyn Droste I. W. Fraser David W. Johnson Peak Mann Mah Kathy Nicholls David Packham Joseph Proietto A. J. Roberts Simon D. Roger Venessa Tsang Roberto Abrão Raduan Fernando Augusto Alves da Costa Celso Amodeo Luiz Alberto Andreotti Turatti Rachel Bregman Fernanda Cristina Camelo Sanches Luís Henrique Santos Canani Antônio Roberto Chacra João Borges Sérgio Vencio Roberto Jorge da Silva Franco Domingos O. d’Avila Evandro de Souza Portes Pedro de Souza

Chronic kidney disease with reduced estimated glomerular filtration rate or elevated albuminuria increases risk for ischemic and hemorrhagic stroke. This study assessed the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on stroke atrial fibrillation/flutter (AF/AFL) from CREDENCE (Canagliflozin Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) a meta-analysis large cardiovascular outcome trials (CVOTs) SGLT2i type diabetes mellitus.CREDENCE randomized...

10.1161/strokeaha.120.031623 article EN cc-by-nc-nd Stroke 2021-04-20
Hiddo J.L. Heerspink David Z.I. Cherney Douwe Postmus Bergur V. Stefánsson Glenn M. Chertow and 95 more Jamie P. Dwyer Tom Greene Mikhail Kosiborod Anna Maria Langkilde John J.V. McMurray Ricardo Correa–Rotter Peter Rossing C. David Sjöström Robert D. Toto David C. Wheeler Hiddo J.L. Heerspink David C. Wheeler Glenn M. Chertow Ricardo Correa–Rotter Tom Greene Fan Fan Hou John J.V. McMurray Peter Rossing Robert D. Toto Bergur V. Stefánsson Anna Maria Langkilde Laura Maffei Pablo Raffaele S. Solís César A. Arias Dov Aizenberg Carolina Lúquez Cesar Javier Zaidman Natalia Cluigt M. Mayer Andres Alvarisqueta A. Wassermann Rafaël Maldonado J. Bittar M. Maurich L.E. Gaite Néstor H. García Louise E. Sivak Pablo Ramallo Juan Carlos Santos Ruben Garcia Duran Juan Oddino A Marañón Lília Nigro Maia Dánae Duana Ávila Elvino Barros Maria H Vidotti Daniel Panarotto Irene de Lourdes Noronha Luiz Alberto Andreotti Turatti Luciane Mônica Deboni María Eugênia Fernandes Canziani Miguel C. Riella Marcelo Rodrigues Bacci Raphael Paschoalin R. J. Franco João Carlos Goldani Eric St-Amour Andrew Steele R. Goldenberg Sanjay Pandeya Harpreet S. Bajaj David Z.I. Cherney Stéphanie Kaiser James Conway Sharron Chow G. Howard Bailey Jean‐Philippe Lafrance Jonathan Winterstein S. Cournoyer D. Gaudet F. Madore Robyn L. Houlden Aaron Dowell Michel R. Langlois Nicola Muirhead Hasnain Khandwala Adeera Levin Fan Fan Hou Ying Xue Lingyan Zuo Chuan‐Ming Hao Zhaohui Ni Xing Changying N. Chen Yugang Dong Rong Zhou Xiao Xu Yiping Zou Chu Wang Liu B Qian Chen Miao Lin Qing Luo D. Zhang

This pre-specified analysis of DAPA-CKD assessed the impact sodium-glucose cotransporter 2 inhibition on abrupt declines in kidney function high-risk patients based having chronic disease (CKD) and substantial albuminuria. was a randomized, double-blind, placebo-controlled trial that had median follow-up 2.4 years. Adults with CKD (urinary albumin-to-creatinine ratio 200–5000 mg/g estimated glomerular filtration rate 25–75 mL/min/1.73m2) were randomized to dapagliflozin 10 mg/day matched...

10.1016/j.kint.2021.09.005 article EN cc-by Kidney International 2021-09-22

Abstract The laparoscopic approach represents the standard of treatment for renal and adrenal diseases, its use is increasing even outside referral centres. Although most procedures are routinely performed, intraoperative complications do not occur, rate predictive factors these have been established. aim this study was to evaluate incidence type identify in patients undergoing surgery. This a cohort, multicentre, international retrospective study. Patients who underwent surgeries between...

10.1038/s41598-024-51696-2 article EN cc-by Scientific Reports 2024-01-16

DEMOGRAPHICS AND HEALTHCARE OF THE ARGENTINEAN REPUBLIC Argentina is a federal republic located in the southern portion of South America, with mainland area 2 780 400 km2. eighth largest country world, and second Latin America. Spanish main language; population has been estimated at 43 847 430 2016, (Figure 1). The Human Development Index as statistical composite life expectancy, education, per capita income indicators ranks 45th worldwide 2016. Healthare provided through combination...

10.1097/tp.0000000000002172 article EN Transplantation 2018-05-20

This prospective pharmacoepidemiological study examined treatment and outcomes in patients converted to sirolimus (SRL) after renal transplantation. 484 subjects 36 centres 7 countries were followed for up 5 years. Principal reasons conversion declining graft function (146/484, 30%) side effects of prior therapy (144/484, the major combinations SRL ± MMF (62%), + TAC (21.5%), CSA (16.5%). The cumulative probability biopsy-confirmed acute rejection (BCAR) was 5% (n = 22), death-censored loss...

10.1155/2012/107180 article EN cc-by Journal of Transplantation 2012-01-01

The impact of renal transplantation (RT) in the elderly with many comorbid conditions is a matter concern. aim our study was to assess RT on survival patients older than 60 years compared those remaining waiting list (WL) according their comorbidities.

10.1097/tp.0000000000003070 article EN Transplantation 2020-01-13

Growing scientific evidence from studies on type 2 diabetes (T2D) has recently led to a better understanding of the associated metabolic–cardio–renal risks. The large amount available information makes it essential have practical guide that summarizes recommendations for initial management patients with T2D, integrating different aspects endocrinology, cardiology, and nephrology. expert consensus presented here does not attempt summarize all in this regard but rather attempts define summary...

10.1007/s13300-020-00961-4 article EN cc-by-nc Diabetes Therapy 2020-12-15

Unknown etiology is usually found in the kidney pre-transplant routine program, which accounts for 25% of our recipients' database. This missing information detriment to prognosis these patients. We developed a preliminary screening detect and study recipients that showed following characteristics: Hypertension with no clear origin, biopsies do not meet clinical features classical glomerulopathies. The aim this explore clinical, genealogical genetic landscape 45 years old index case early...

10.1016/j.ekir.2024.02.727 article EN cc-by-nc-nd Kidney International Reports 2024-04-01

Focal segmental glomerulosclerosis (FSGS) is a common glomerular disorder that manifests clinically with nephrotic syndrome and >80% sloughing or loss of primary foot cells. After renal transplantation, recurrence GSFS occurs in 30% to 50% adults. The objective our study analyze the presence podocyturia evolution proteinuric nephropathies its characterization as an early marker injury.

10.1016/j.ekir.2024.02.1052 article EN cc-by-nc-nd Kidney International Reports 2024-04-01

Focal segmental glomerulosclerosis (FSGS) recurs in 30-60%, being associated with a five-fold increased risk of graft loss. The recurrence is initially ultrastructural (for which optical microscopy reports minimal change disease, MCD) manifesting proteinuria or anuria. To date, there are no treatment guidelines that demonstrate efficacy while facing this issue. We will describe the diagnostic, preventive and therapeutic experience regarding recurrent FSGS at Fundación Favaloro University...

10.1016/j.ekir.2024.02.1006 article EN cc-by-nc-nd Kidney International Reports 2024-04-01

In Argentina, only 20% of patients on the Waiting List undergo transplants annually. For this reason, procured kidneys are a scarce resource. About discarded many cases there is discrepancy in criteria between Transplant Teams to accept or reject an organ. analysis evolution that were implanted compared pair had been by rest teams was carried out

10.1016/j.ekir.2024.02.989 article EN cc-by-nc-nd Kidney International Reports 2024-04-01

Abstract Background and Aims Organ crosstalk in heart failure kidney dysfunction is prevalent associated to a high event rate. In this setting elevated serum creatinine (sCr) at acute decompensated (ADHF) admissions strong risk factor for poor outcomes. Current accepted cardiorenal syndrome (CRS) classification based on timing initial organ fails capturing its nature prognosis. We sought describe patient (P) profile outcomes P hospitalized ADHF with admission sCr function of current CRS...

10.1093/ndt/gfae069.1140 article EN other-oa Nephrology Dialysis Transplantation 2024-05-01
Coming Soon ...